1. Home
  2. List
Reference Patent

Reference - List

  • 22 Hits
  • Search Condition : Filter (MeSH = Recombinant Fusion Proteins / pharmacology)
Species Resource Title
Human and Animal Cells 293T(RCB2202) An Immunoreceptor-Targeting Strategy with Minimalistic C3b Peptide Fusion Enhances SARS-CoV-2 RBD mRNA Vaccine Immunogenicity.
Human and Animal Cells SHP1^(-) DT40(RCB1466) , SHP1^(-)/SHP2^(-) DT40(RCB1501) , SHP2^(-) DT40(RCB1502) , SHIP^(-) DT40(RCB1465) Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling.
Human and Animal Cells 10T1/2(RCB0247) Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin.
Human and Animal Cells BALB/3T3 clone A31(RCB0005) Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
Human and Animal Cells MG-63(RCB1890) Inhibition of vitronectin-mediated haptotaxis and haptoinvasion of MG-63 cells by domain 5 (D5(H)) of human high-molecular-weight kininogen and identification of a minimal amino acid sequence.
Human and Animal Cells ST2(RCB0224) Rab27a and Rab27b are involved in stimulation-dependent RANKL release from secretory lysosomes in osteoblastic cells.
DNA material pGEX-6P-3/GST-TAT-ODD/3-0-Casp3 (RDB14403) , pEF/HRE-Fluc (RDB14404). Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model.
Human and Animal Cells 10T1/2(RCB0247) Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Human and Animal Cells The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
Human and Animal Cells Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Human and Animal Cells MC3T3-E1(RCB1126) , C2C12(RCB0987) Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.
Human and Animal Cells ST2(RCB0224) Characterization of structural domains of human osteoclastogenesis inhibitory factor.
Human and Animal Cells 293T(RCB2202) Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent.
Human and Animal Cells 253G1(HPS0002) , 201B7(HPS0063) Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein.
Cellular slime molds S00486 A putative receptor mediating cell-density sensing in Dictyostelium.
DNA material pGa981-6 (RDB06776) Roles of the ankyrin repeats and C-terminal region of the mouse notch1 intracellular region.
Human and Animal Cells MKN45(RCB1001) , MKN28(RCB1000) Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein.
Human and Animal Cells Saos-2(RCB0428) Efficient growth inhibition of human osteosarcoma cells using a peptide derived from the MDM-2-binding site of p53.
Human and Animal Cells F-36E(RCB0776) Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin.
Human and Animal Cells F-36E(RCB0776) The prolonged half-lives of new erythropoietin derivatives via peptide addition.